Full Text View
Tabular View
No Study Results Posted
Related Studies
An Efficacy and Safety Study of Ixmyelocel-T in Patients With Critical Limb Ischemia (CLI) (REVIVE)
This study is ongoing, but not recruiting participants.
Study NCT01483898   Information provided by Vericel Corporation

First Received on November 30, 2011.   Last Updated on July 17, 2013   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Additional conditions recognized in this trial
More general conditions related to this trial
Interventions listed in this trial
Sponsors listed in this trial